Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harrys A Torres

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
Journal of Hepatocellular Carcinoma|August 11, 2016
Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case seriesHarrys A Torres, Ahmed Kaseb, Parag Mahale, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 8, 2015
Hepatocellular carcinoma as a second primary cancer in patients with chronic hepatitis C virus infectionParag Mahale, Ahmed O Kaseb, Manal M Hassan, et al.
Hematological Oncology|March 21, 2020
Clinicopathologic characteristics of follicular lymphoma in hepatitis C virus-infected patientsJeff Hosry, Roberto N Miranda, Felipe Samaniego, et al.
Leukemia & Lymphoma|September 25, 2015
The effect of different rituximab-containing chemotherapy strategies on hepatitis C viremiaParag Mahale, Francesco Turturro, Jorge E Romaguera, et al.
International Journal of Cancer|October 20, 2017
Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patientsJeff Hosry, Roberto N Miranda, Felipe Samaniego, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 22, 2023
False-reactive hepatitis B surface antigen test results in cancer patientsJoseph T Klingen, Khalis Mustafayev, Marcel Yibirin, et al.
Diagnostic Microbiology and Infectious Disease|May 23, 2022
Impact of CD4+ T-cell count on sustained virologic response to direct-acting antivirals in hepatitis C virus monoinfected cancer patients: a prospective observational studyGeorgios Angelidakis, Haley Pritchard, Marcel Yibirin, et al.
Transplantation and Cellular Therapy|August 28, 2022
Hepatitis E Virus Infection in Cancer PatientsChia-Yu Chiu, Hao Chi Zhang, Jason Westin, et al.
Journal of Hepatology|June 4, 2016
Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatmentHarrys A Torres, Jean-Nicolas Vauthey, Minas Platon Economides, et al.
Oral Oncology|August 30, 2018
Chronic hepatitis C virus infection in patients with nonoropharyngeal head and neck cancersGeorgios Angelidakis, Erich M Sturgis, Minas P Economides, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Journal of Hepatocellular Carcinoma|August 11, 2016
Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case seriesHarrys A Torres, Ahmed Kaseb, Parag Mahale, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 8, 2015
Hepatocellular carcinoma as a second primary cancer in patients with chronic hepatitis C virus infectionParag Mahale, Ahmed O Kaseb, Manal M Hassan, et al.
Hematological Oncology|March 21, 2020
Clinicopathologic characteristics of follicular lymphoma in hepatitis C virus-infected patientsJeff Hosry, Roberto N Miranda, Felipe Samaniego, et al.
Leukemia & Lymphoma|September 25, 2015
The effect of different rituximab-containing chemotherapy strategies on hepatitis C viremiaParag Mahale, Francesco Turturro, Jorge E Romaguera, et al.
International Journal of Cancer|October 20, 2017
Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patientsJeff Hosry, Roberto N Miranda, Felipe Samaniego, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 22, 2023
False-reactive hepatitis B surface antigen test results in cancer patientsJoseph T Klingen, Khalis Mustafayev, Marcel Yibirin, et al.
Diagnostic Microbiology and Infectious Disease|May 23, 2022
Impact of CD4+ T-cell count on sustained virologic response to direct-acting antivirals in hepatitis C virus monoinfected cancer patients: a prospective observational studyGeorgios Angelidakis, Haley Pritchard, Marcel Yibirin, et al.
Transplantation and Cellular Therapy|August 28, 2022
Hepatitis E Virus Infection in Cancer PatientsChia-Yu Chiu, Hao Chi Zhang, Jason Westin, et al.
Journal of Hepatology|June 4, 2016
Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatmentHarrys A Torres, Jean-Nicolas Vauthey, Minas Platon Economides, et al.
Oral Oncology|August 30, 2018
Chronic hepatitis C virus infection in patients with nonoropharyngeal head and neck cancersGeorgios Angelidakis, Erich M Sturgis, Minas P Economides, et al.
Pageof 12